Literature DB >> 22513052

IL-1, quo vadis?

Alena Grebe1, Eicke Latz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22513052      PMCID： PMC3623936          DOI： 10.1016/j.atherosclerosis.2012.03.010

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  11 in total

1.  Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).

Authors:  Paul M Ridker; Tom Thuren; Andrew Zalewski; Peter Libby
Journal:  Am Heart J       Date:  2011-09-14       Impact factor: 4.749

2.  Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.

Authors:  Shay Shemesh; Yehuda Kamari; Aviv Shaish; Sarita Olteanu; Michal Kandel-Kfir; Tal Almog; Itamar Grosskopf; Ron N Apte; Dror Harats
Journal:  Atherosclerosis       Date:  2011-12-17       Impact factor: 5.162

3.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

Review 4.  The inflammasomes: mechanisms of activation and function.

Authors:  Eicke Latz
Journal:  Curr Opin Immunol       Date:  2010-01-08       Impact factor: 7.486

Review 5.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

6.  Active caspase-1 is a regulator of unconventional protein secretion.

Authors:  Martin Keller; Andreas Rüegg; Sabine Werner; Hans-Dietmar Beer
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

Review 7.  Immune and inflammatory mechanisms of atherosclerosis (*).

Authors:  Elena Galkina; Klaus Ley
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 8.  Immunological and inflammatory functions of the interleukin-1 family.

Authors:  Charles A Dinarello
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene.

Authors:  M J Nicklin; D E Hughes; J L Barton; J M Ure; G W Duff
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

Review 10.  Cytokines and atherosclerosis: a comprehensive review of studies in mice.

Authors:  Robert Kleemann; Susanne Zadelaar; Teake Kooistra
Journal:  Cardiovasc Res       Date:  2008-05-16       Impact factor: 10.787
View more
  1 in total

1.  Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes.

Authors:  M Herly; K Stengaard-Pedersen; K Hørslev-Petersen; M L Hetland; M Østergaard; R Christensen; B B Løgstrup; P Vestergaard; J Pødenphant; P Junker; T Ellingsen
Journal:  BMJ Open       Date:  2017-04-08       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.